Physician

Alan Millman, MD

According to 2025 Medicare claims, Alan Millman, MD (NPI: 1366478471) practices neurology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MILLMAN NEUROLOGY PLLC (NPI: 1639841687) and primary practice location at 48346-2090.

Millman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 620 HCPCS/CPT codes, and received $68,541 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 934 prescription claims across 217 beneficiaries totaling $112,607 in drug costs, led by Rivastigmine (Rivastigmine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $121,810 to $68,541. Similarly, Part D prescription costs have fallen sharply in recent years, from $491,979 to $112,607. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$135K2015 Medicare payment: $121,810 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $134,784 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $113,153 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $70,149 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $116,048 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $126,543 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $94,738 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $25,243 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $57,024 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $68,541 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156131,445$121,810
20166181,588$134,784
20176371,445$113,153
2018409836$70,149
20194601,766$116,048
20205351,620$126,543
20213841,242$94,738
202264194$25,243
2023139475$57,024
2024170620$68,541

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$559K$1.1M2015 Drug cost: $491,979 (USD; Tot_Drug_Cst)2016 Drug cost: $574,093 (USD; Tot_Drug_Cst)2017 Drug cost: $1,118,135 (USD; Tot_Drug_Cst)2018 Drug cost: $492,515 (USD; Tot_Drug_Cst)2019 Drug cost: $48,576 (USD; Tot_Drug_Cst)2020 Drug cost: $125,454 (USD; Tot_Drug_Cst)2021 Drug cost: $107,055 (USD; Tot_Drug_Cst)2022 Drug cost: $68,721 (USD; Tot_Drug_Cst)2023 Drug cost: $63,854 (USD; Tot_Drug_Cst)2024 Drug cost: $112,607 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153221,324$491,979
20163201,601$574,093
20173311,701$1,118,135
2018324859$492,515
2019193536$48,576
20203271,086$125,454
2021260907$107,055
202256159$68,721
2023146595$63,854
2024217934$112,607

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95911Nerve conduction, 9-10 studies3030$164
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9797$119
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7196$98
95886Needle measurement of electrical activity in arm or leg muscles, complete study3393$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more110217$67

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RivastigmineRivastigmine1387,920$35,677
GlatopaGlatiramer Acetate11330$15,783
Carbidopa-LevodopaCarbidopa/Levodopa945,704$3,481
Pyridostigmine BromidePyridostigmine Bromide121,020$3,439
Memantine HclMemantine Hcl765,241$2,919

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alan Millman, MD?

Tedicare shows public-source Medicare data for Alan Millman, MD (NPI 1366478471), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Millman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Millman, MD?

Alan Millman, MD is linked to MILLMAN NEUROLOGY PLLC (billing NPI 1639841687) in the available physician profile data.

Does Alan Millman, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.